Sandeep S. Dave

Sandeep S. Dave

Professor of Medicine

Appointments and Affiliations

  • Professor of Medicine
  • Member of the Duke Cancer Institute

Contact Information

  • Office Location: 101 Science Drive, CIEMAS 2177C, Box 3382, Durham, NC 27710
  • Office Phone: (919) 681-1922
  • Email Address: sandeep.dave@duke.edu
  • Websites:

Education

  • National Institutes of Health, 2007
  • Northwestern University, 2001
  • M.D. Northwestern University, 1999

In the News

Representative Publications

  • Lee, MJ; Koff, JL; Switchenko, JM; Jhaney, CI; Harkins, RA; Patel, SP; Dave, SS; Flowers, CR, Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma., Cancer, vol 126 no. 15 (2020), pp. 3493-3503 [10.1002/cncr.32866] [abs].
  • Fedoriw, Y; Selitsky, S; Montgomery, ND; Kendall, SM; Richards, KL; Du, W; Tomoka, T; Mulenga, M; Parker, JS; Dave, SS; Gopal, S, Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from Malawi., Modern Pathology, vol 33 no. 8 (2020), pp. 1482-1491 [10.1038/s41379-020-0506-3] [abs].
  • Shingleton, JR; Dave, SS, Polatuzumab Vedotin: Honing in on Relapsed or Refractory Diffuse Large B-Cell Lymphoma., Journal of Clinical Oncology, vol 38 no. 2 (2020), pp. 166-168 [10.1200/JCO.19.02587] [abs].
  • Holkova, B; Shafer, D; Yazbeck, V; Dave, S; Bose, P; Tombes, MB; Shrader, E; Wan, W; Bandyopadhyay, D; Weir, C; Collins, EB; Garnett, A; Kmieciak, M; Roberts, JD; Garcia-Manero, G; Grant, S, Phase 1 study of belinostat (PXD-101) and bortezomib (Velcade, PS-341) in patients with relapsed or refractory acute leukemia and myelodysplastic syndrome, Leukemia & Lymphoma (2020) [10.1080/10428194.2020.1861270] [abs].
  • Li, X; Kositsky, R; Reddy, A; Love, C; Naresh, K; Koff, JL; Nystrand, I; Leppä, S; Pasanen, A; Karjalainen-Lindsberg, M-L; Dunkel, J; Kovanen, P; Qin, Q; Bhagat, G; Leeman-Neill, RJ; Goswami, RS; Wildeman, S; Delabie, J; Burack, R; Evans, AG; Amador, C; Yuan, J; Qureishi, HN; Li, S; Xu, J; Yin, CC; Gang, AO; Norgaard, PH; Pedersen, MØ; Chan, JY; Cheah, DMZ; Ong, SY; Cheng, CL; Lee, L; Paulua, F; Ondrejka, SL; Hsi, ED; Czader, M; Wang, L; Landis, A; Churnetski, MC; Jaye, DL; Flowers, CR; McCall, CM; Neff, J; McKinney, MS; Fedoriw, Y; Powers, E; Montgomery, ND; Bogusz, AM; Stafford Hintz, A; Kovach, AE; Reddy, N; Thompson Arildsen, MA; Mason, EF; Juskevicius, R; Choi, W; Au-Yeung, R; Tse, E; Sarno, V; Chadburn, A; Lopez, R; Chapman, JR; Behdad, A; Goldschmidt, N; Goodlad, J; Burton, C; Pillai, R; Louissaint, A; Soliman, DS; Panea, R; Dave, T; Xiong, B; Smith, E; Dave, S, Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma., Blood, vol 134 no. Supplement_1 (2019) [10.1182/blood-2019-130255] [abs].